Track topics on Twitter Track topics that are important to you
Since its founders developed one of the worldâs first cochlear implants in the 1970s, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems, currently used in 96 countries, combine the latest scientific advances, engineering and manufacturing techniques for performance, safety and reliability. MED-EL offers the broadest portfolio of hearing implant systems, including the MAESTRO Cochlear Implant system for those with severe-to-profound sensorineural hearing loss and the unique Vibrant SoundbridgeÂ®, a middle ear prosthesis for the treatment of moderate to severe sensorineural hearing loss. The fast-growing medical technology company employs more than 1,000 people worldwide, more than 650 of whom are based at the companyâs headquarters in Innsbruck, where R&D and production are located. For more information, visit www.medel.com or call 888-MED-EL-CI (633-3524).
CALGARY, ALBERTA -- (Marketwired) -- 08/08/16 -- Vivione Biosciences Inc. ("Vivione" or the "Corporation") (NEX: VBI.H) is pleased to announce that it has completed the previously announced shares f...
Oriola-KD Corporation Stock Exchange Release 4 January 2017 at 9.00 a.m. Oriola-KD Corporation's 50,375 A-shares converted into B-shares In accordance with Section 3 of the Byla...
Oriola-KD Corporation Stock Exchange Release 7 October 2016 at 2.00 p.m. Oriola-KD Corporation will publish the interim report 1 January - 30 September 2016 on Thursday, 20 October 201...
Oriola-KD Corporation Stock Exchange Release 24 November 2016 at 1.00 p.m. Publication schedule for Oriola-KD Corporation's financial reporting in 2017 Oriola-KD Corporation will...
LINCOLN, NE--(Marketwired - August 30, 2016) - National Research Corporation (NASDAQ: NRCIA) (NASDAQ: NRCIB) today announced that its Board of Directors has declared a quarterly cash dividend of $0.0...
This is a correction of the announcement from 14:00 07.10.2016 EEST. Reason for the correction: There was an error considering the meeting schedule for investors, analysts and the pre...
Oriola-KD Corporation Stock Exchange Release 4 November 2016 at 12.00 Oriola-KD Corporation: Notification of managers' transactions ...
ORION CORPORATION STOCK EXCHANGE RELEASE 22 DECEMBER 2016 at 9.00 a.m. EET 87,000 Orion Corporation A shares converted into B shares In accor...
Quorum Health Corporation will be an operator and manager of general acute care hospitals and outpatient services in the United States. QHC will own or lease a diversified portfol...
We have published hundreds of MED-EL Corporation news stories on BioPortfolio along with dozens of MED-EL Corporation Clinical Trials and PubMed Articles about MED-EL Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MED-EL Corporation Companies in our database. You can also find out about relevant MED-EL Corporation Drugs and Medications on this site too.
Hearing, auditory perception, or audition is the ability to perceive sound by detecting vibrations, changes in the pressure of the surrounding medium through time, through an organ such as the ear. Sound may be heard through solid, liquid, or gaseous mat...